Nomogram predicting recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes
This validated model estimates the 5-year risk of recurrence and melanoma-specific mortality in melanoma patients with negative sentinel lymph nodes (c-index for the recurrence model was 0.74 and 0.76 for the calibrated model for melanoma-specific mortality).

The model is not appropriate for melanoma patients who did not undergo sentinel lymph node biopsy or those who have positive sentinel lymph nodes. 
Research authors: D. Verver, D. van Klaveren, V. Franke, A.C.J. van Akkooi, P. Rutkowski, U. Keilholz, A.M.M. Eggermont, T. Nijsten, D.J. Grunhagen, C. Verhoef, A. Rekkas (online model)
Details Files & References
Composite
Model author
Version
1.17
Revision date
2020-01-30
Specialty
MeSH terms
  • Melanoma
  • Status
    public
    Share

    {{ resultSubheader }}

    {{ model.survival.PITTitle }}

    {{ model.survival.YNETitle }}

    Results
    Note
    Notes are only visible in the result download and will not be saved by Evidencio

    Composite model

    Conditional information

    Result interpretation

    {{ file.classification }}

    Calculations alone should never dictate patient care, and are no substitute for professional judgement. See our full disclaimer.

    Comments
    Rating
    Comment
    Please enter a comment of rating
    Comments are visible to anyone

    Model feedback

    No feedback yet 1 Comment {{ model.comments.length }} Comments
    Not rated | On {{ comment.created_at }} {{ comment.user.username }} a no longer registered author wrote: